Legend Financial Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7
Closed -$68 122
2025
Q2
$68 Buy
+7
New +$72 ﹤0.01% 170
2025
Q1
Sell
-25
Closed -$373 177
2024
Q4
$373 Buy
25
+18
+257% +$293 ﹤0.01% 231
2024
Q3
$134 Sell
7
-18
-72% -$373 ﹤0.01% 152
2024
Q2
$518 Buy
25
+17
+213% +$338 ﹤0.01% 256
2024
Q1
$150 Buy
8
+6
+300% +$103 ﹤0.01% 185
2023
Q4
$29 Buy
+2
New +$27 ﹤0.01% 193
2023
Q3
Sell
-10
Closed -$208 209
2023
Q2
$208 Hold
10
﹤0.01% 206
2023
Q1
$235 Sell
10
-5
-33% -$134 ﹤0.01% 229
2022
Q4
$420 Buy
15
+6
+67% +$153 ﹤0.01% 242
2022
Q3
$199 Buy
+9
New +$272 ﹤0.01% 233

Other funds holding OGN

Legend Financial Advisors's OGN Position: Q3 2025 in Review

Legend Financial Advisors sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 7 shares — an estimated $68 sold.

Legend Financial Advisors first reported a position in OGN in Q3 2022 and held it in 10 quarters. The position peaked at $518 in Q2 2024. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Legend Financial Advisors reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • Legend Financial Advisors sold 7 Organon & Co shares in Q3 2025, an estimated $68.
  • Legend Financial Advisors first reported a position in Organon & Co in Q3 2022 and held it in 10 quarters.
  • Legend Financial Advisors's Organon & Co position peaked at $518 in Q2 2024.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Legend Financial Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.